Your browser doesn't support javascript.
loading
Autoantibodies against ACE2 and angiotensin type-1 receptors increase severity of COVID-19.
Rodriguez-Perez, Ana I; Labandeira, Carmen M; Pedrosa, Maria A; Valenzuela, Rita; Suarez-Quintanilla, Juan A; Cortes-Ayaso, María; Mayán-Conesa, Placido; Labandeira-Garcia, Jose L.
Afiliación
  • Rodriguez-Perez AI; Research Center for Molecular Medicine and Chronic Diseases (CIMUS), IDIS, University of Santiago de Compostela, Santiago de Compostela, Spain; Networking Research Center on Neurodegenerative Diseases (CIBERNED), Spain.
  • Labandeira CM; Research Center for Molecular Medicine and Chronic Diseases (CIMUS), IDIS, University of Santiago de Compostela, Santiago de Compostela, Spain; Hospital Alvaro Cunqueiro, University Hospital Complex, Vigo, Spain.
  • Pedrosa MA; Research Center for Molecular Medicine and Chronic Diseases (CIMUS), IDIS, University of Santiago de Compostela, Santiago de Compostela, Spain; Networking Research Center on Neurodegenerative Diseases (CIBERNED), Spain.
  • Valenzuela R; Research Center for Molecular Medicine and Chronic Diseases (CIMUS), IDIS, University of Santiago de Compostela, Santiago de Compostela, Spain; Networking Research Center on Neurodegenerative Diseases (CIBERNED), Spain.
  • Suarez-Quintanilla JA; Primary Health-Care Unit Fontiñas, IDIS, University of Santiago de Compostela, Santiago de Compostela, Spain.
  • Cortes-Ayaso M; Emergency Department, University Clinical Hospital of Santiago, Santiago de Compostela, Spain.
  • Mayán-Conesa P; Emergency Department, University Clinical Hospital of Santiago, Santiago de Compostela, Spain.
  • Labandeira-Garcia JL; Research Center for Molecular Medicine and Chronic Diseases (CIMUS), IDIS, University of Santiago de Compostela, Santiago de Compostela, Spain; Networking Research Center on Neurodegenerative Diseases (CIBERNED), Spain. Electronic address: joseluis.labandeira@usc.es.
J Autoimmun ; 122: 102683, 2021 08.
Article en En | MEDLINE | ID: mdl-34144328

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Autoanticuerpos / Autoantígenos / Receptor de Angiotensina Tipo 1 / Enzima Convertidora de Angiotensina 2 / COVID-19 Tipo de estudio: Prognostic_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Autoimmun Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: España Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Autoanticuerpos / Autoantígenos / Receptor de Angiotensina Tipo 1 / Enzima Convertidora de Angiotensina 2 / COVID-19 Tipo de estudio: Prognostic_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Autoimmun Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: España Pais de publicación: Reino Unido